Fernando Padilla - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Fernando Padilla

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Bioorganic & Medicinal Chemistry Letters|April 27, 2010

Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.

Journal of Medicinal Chemistry|January 29, 2013

Pyrrolopyrazines as selective spleen tyrosine kinase inhibitorsFernando Padilla, Niala Bhagirath, Shaoqing Chen, et al.

Journal of Medicinal Chemistry|May 26, 2012

Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibitionBrian S Safina, Stewart Baker, Matt Baumgardner, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Bioorganic & Medicinal Chemistry Letters|April 27, 2010

Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.

Journal of Medicinal Chemistry|January 29, 2013

Pyrrolopyrazines as selective spleen tyrosine kinase inhibitorsFernando Padilla, Niala Bhagirath, Shaoqing Chen, et al.

Journal of Medicinal Chemistry|May 26, 2012

Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibitionBrian S Safina, Stewart Baker, Matt Baumgardner, et al.

Pageof 5